Literature DB >> 24616248

Predictors for prolonged hospital stay after transcatheter mitral valve repair with the MitraClip.

Jakob Ledwoch1, Stefan Bertog, Nina Wunderlich, Mirko Doss, Stephan Fichtlscherer, Tobias Teufel, Tina Herholz, Laura Vaskelyte, Ilona Hofmann, Horst Sievert.   

Abstract

OBJECTIVE: The aim is to find predictors for a prolonged LOHS after MitraClip implantation.
BACKGROUND: Due to its less invasive nature, average length of hospital stay (LOHS) after the MitraClip procedure is shorter compared to mitral valve surgery. However, some patients have a prolonged LOHS.
METHODS: Records of consecutive patients who underwent MitraClip procedure were reviewed. A total of 41 consecutive patients with MitraClip implantation (76 ± 9 years, 59% men) were included. Median hospital stay was 7 days. Hospitalization lasting longer than 7 days was considered prolonged.
RESULTS: Procedural success was achieved in 88% of the cases. In-hospital death occurred in 4 of 41 patients (10%). Patients with a prolonged hospital stay (46%) had a higher EuroSCORE I (22.7% [IQR 10.3-28.3] vs. 6.7% [IQR 3.5-18.3], P = 0.017), a higher STS mortality score (6.1%[(IQR 3.7-7.5] vs. 2.6% [IQR 1.4-4.8]; P = 0.043) and a higher STS long-length-of-stay score (18.9% [IQR 11.3-22.5] vs. 9.6% [IQR 6.2-16.1]; P = 0.039) as well as a lower estimated glomerular filtration rate (eGFR) (41 ml/min/1.73 m(2) [IQR 19-52] vs. 56 ml/min/1.73 m(2) [IQR 49-62]; P = 0.008) than those whose did not. In the multivariate model, lower eGFR was identified as predictor for a prolonged hospitalization.
CONCLUSION: Lower pre-procedure eGFR is independently associated with a longer hospitalization.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  MitraClip; hospital stay; hospitalization; percutaneous mitral valve repair; predictor

Mesh:

Year:  2014        PMID: 24616248     DOI: 10.1002/ccd.25460

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Hannes Tabert; Niklas Boeder; Matthias Bayer; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

2.  Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Regine M Ortlieb; Niklas Boeder; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-11-16       Impact factor: 2.882

3.  Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR.

Authors:  Johannes Patzelt; Miriam Ulrich; Annika Becker; Karin A L Müller; Rezo Jorbenadze; Michal Droppa; Wenzhong Zhang; Sarah Mandel; Lisa Habel; Henning Lausberg; Janine Pöss; Tobias Geisler; Oliver Borst; Peter Rosenberger; Christian Schlensak; Meinrad Gawaz; Jürgen Schreieck; Peter Seizer; Harald F Langer
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

Review 4.  Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review.

Authors:  Kevin Bryan Lo; Sandeep Dayanand; Pradhum Ram; Pradeep Dayanand; Leandro N Slipczuk; Vincent M Figueredo; Janani Rangaswami
Journal:  Curr Cardiol Rev       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.